The New York Buyers’ Club now stocks Niatab 500 from Douglas Labs. This timed-release product is better tolerated than regular Niacin formulas (that is, minimizes flushing, which can be bothersome to some), and may be especially helpful to those who are using Niacin on a regular basis in managing their cholesterol.
With federally-funded research now pointing to Niacin + a statin drug as the new standard of preventive care for cardiovascular disease, this is a very welcome addition to the Douglas Labs line. For background on the recent revival of interest in Niacin, see “An Old Cholesterol Remedy is New Again,” by Michael Mason in The New York Times, Jan. 23, 2007.
Niatab™ 500 tablets, provided by Douglas Laboratories®, slowly release 500 mg of pure niacin. Sustained release niacin is better tolerated than regular crystalline high-potency niacin supplements. Niatab 500 is a scored uncoated tablet which can be broken in half when lower dosage is desired.
Alderman JD et al. Effect of a modified, well-tolerated niacin regimen on serum total cholesterol, high density lipoprotein cholesterol and the cholesterol to high density lipoprotein ratio. Am J Cardiol 1989;64:725-729.
Canner PL et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol 1986;8:1245-1255.
Colletti RB et al. Niacin treatment of hypercholesterolemia in children. Pediatrics 1993;92:78-82.
Keenan JM et al. Niacin revisited: a randomized, controlled trial of wax-matrix sustained-release niacin in hypercholesterolemia. Arch Intern Med 1991;151:1424-1432.
Lavie CJ et al. Marked benefit with sustained-release niacin therapy in patients with ‘isolated’ very low levels of high-density lipoprotein cholesterol and coronary artery disease. Am J Cardiol 1992;69:1083-1085.
Probstfield JL. Nicotinic acid as a lipoprotein-altering agent: therapy directed by the primary physician. Arch Int Med 1994;154:1557-1559.
Product Description and References from: Douglas Labs Product Info Sheet